title: Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
authors.affiliation: Transplantation Laboratory, University of Helsinki, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Yilmaz
authors.forename: E
authors.initials: E
authors.lastname: Taskinen
authors.forename: P
authors.initials: P
authors.lastname: Häyry
authors.forename: H
authors.initials: H
authors.lastname: Isoniemi
mesh_terms: D001706:Biopsy; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects; D003937:Diagnosis, Differential; D006084:Graft Rejection / Q000473:pathology*; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology* / Q000502:physiology; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology / Q000502:physiology
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine